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ABSTRACT: The ethyl acetate extract of an endophyte Epicoccum sorghinum exhibited
anti-inflammatory activity at a concentration of <10 μg/mL. By bioassay-guided
fractionation, one new compound, named epicorepoxydon A (1), and one unusual
bioactive compound, 6-(hydroxymethyl)benzene-1,2,4-triol (6), together with six known
compounds, were isolated from E. sorghinum. The structures of all isolates were
established by spectroscopic analyses. The relative configuration of 1 was deduced by the
NOESY spectrum and its absolute configuration was determined by X-ray single-crystal
analysis. The biological activities of all isolates were evaluated using four types of
bioassays including cytotoxicity, anti-inflammatory, antiplatelet aggregation, and
antiangiogenesis activities. Compounds 4 and 6 showed potent anti-inflammatory
activity, compound 2 possessed potent antiplatelet aggregation and antiangiogenesis
activities, and compound 6 demonstrated antiangiogenesis activity. This fungal species
can cause a human hemorrhagic disorder known as onyalai. In this study, we identified
the active components with antiplatelet aggregation and antiangiogenesis activities, which may be related to the hemorrhagic
disorder caused by this fungus. Moreover, we proposed a biosynthetic pathway of the isolated polyketide secondary metabolites and
investigated their structure−activity relationship (SAR). Our results suggested that E. sorghinum is a potent source of biologically
active compounds that can be developed as antiplatelet aggregation and anti-inflammatory agents.
■ INTRODUCTION
Natural products from terrestrial plants, microbial organisms,
and marine organisms played a key role in drug discovery and
development throughout the last two centuries. Many current
therapeutic drugs have their origins from natural products or
their derivatives.1,2 Mother Nature provided humanity with
continuous sources of medicinal bioactive components that
were active against numerous diseases.2−4 Among the major
sources of biologically active compounds are fungi. They
produce diverse groups of bioactive secondary metabolites,
which have been utilized in food, agriculture, or pharmaceut-
ical industries such as cyclosporine, lovastatin, and penicillin.1,2
Endophytic fungi, which reside in inter- and/or intracellular
parts of plants, are known to enhance host growth and
generate numerous prominent bioactive secondary metabo-
lites.5−7 These fungi may improve plants’ ability to stand for
various types of living stresses and increase their resistance to
insects and pests.6,7 Therefore, the chemical and biological
exploration of endophytic fungi continued to be helpful for the
discovery of bioactive natural products.
Continuing our effort in discovering the chemical diversity
and biological activities of natural compounds,8−10 the fungal
strain Epicoccum sorghinum, isolated from the stem of Arundo
donax Linn, was investigated due to the potent anti-
inflammatory activity of its ethyl acetate (EtOAc) crude
extract at a concentration of <10 μg/mL. Few phytochemical
investigations have focused on this plant and its endophytic
fungi. Indole derivatives were isolated from A. donax, which
was collected from the Dr. Cecilia Koo Botanic Conservation
Center (KBCC) after seasonal pruning.11,12 E. sorghinum is
considered as a major component of the sorghum grain-mold
disease complex and potent producer of tenuazonic acid
(TeA).13 This mycotoxin is a tetrameric acid derivative and has
the potential to inhibit protein biosynthesis.13,14 Sorghum is
regarded as the fifth most important cereal crop around the
world.15 Fungal contamination is deemed as one of the major
problems associated with cereal crop production because some
Received: March 5, 2020
Accepted: April 24, 2020
Published: May 6, 2020
Articlehttp://pubs.acs.org/journal/acsodf
© 2020 American Chemical Society
11092
https://dx.doi.org/10.1021/acsomega.0c01000
ACS Omega 2020, 5, 11092−11099
This is an open access article published under an ACS AuthorChoice License, which permits
copying and redistribution of the article or any adaptations for non-commercial purposes.
D
ow
nl
oa
de
d 
vi
a 
U
N
IV
 O
F 
SZ
EG
ED
 o
n 
Ju
ly
 1
9,
 2
02
0 
at
 1
8:
09
:0
1 
(U
TC
).
Se
e 
ht
tp
s:/
/p
ub
s.a
cs
.o
rg
/sh
ar
in
gg
ui
de
lin
es
 fo
r o
pt
io
ns
 o
n 
ho
w
 to
 le
gi
tim
at
el
y 
sh
ar
e 
pu
bl
ish
ed
 a
rti
cl
es
.
fungal species such as Epicoccum species can generate
mycotoxins, which are harmful to humans and animals.13,15
Certain species of Epicoccum cause a human hemorrhagic
disorder known as onyalai.13 Epicoccum species can contam-
inate various foods and beverages and cause leaf spot disease in
different types of plants.13,15
Onyalai is a hemorrhagic disorder that is characterized by
the presence of blood blisters in the mouth and a form of
thrombocytopenic purpura.13,16 This disease results from
eating sorghum grains contaminated with E. sorghinum.
However, no direct correlation was identified between onyalai
and compounds isolated from E. sorghium. Explaining the
pathology of onyalai disease needs rigorous, comprehensive,
and even long-term investigations. Advanced evidence needs to
be explored in the future.
Several studies on Epicoccum species demonstrated a
diversity of chemical components and a broad spectrum of
biological activities.17−19 However, few studies focused on the
secondary metabolites and their biological activities of E.
sorghium.20,21 Therefore, we performed an extensive chemical
and biological investigation on this fungus and identified eight
secondary metabolites, including one new compound,
epicorepoxydon A (1), one unusual bioactive compound, 6-
(hydroxymethyl)benzene-1,2,4-triol (6), one known ethyl
phenyl-skeleton derivative, and five known benzyl-skeleton
derivatives (Figure 1). The structure of 6 was illustrated in the
PubChem database and no reference was reported.
Herein, we report the structural elucidation of a new
compound (1) and its absolute configuration, which was
deduced by X-ray single crystal analysis. We evaluated the
cytotoxicity, anti-inflammatory, antiplatelet aggregation, and
antiangiogenesis activities of all isolates to identify the
secondary metabolites responsible for onyalai and all possible
potential applications of this fungus. We also proposed a
biosynthetic pathway of the isolated polyketide secondary
metabolites and the structure−activity relationship (SAR) of
the isolates.
■ RESULTS AND DISCUSSION
Compound 1 was obtained as brown acicular crystals. The
molecular formula of C15H16O7 was suggested for 1 based on a
deprotonated molecular ion at m/z 307.0822 [M − H]− in the
negative mode HR-ESI-MS and 13C NMR data indicating eight
degrees of unsaturation. The IR spectrum absorption bands at
3448 and 1635 cm−1 implied hydroxyl and carbonyl
functionalities, respectively. The 1H NMR spectrum (Table
1) showed the presence of one methyl group at δH 2.56 (s),
one methylene at δH 4.27 (s), three oxygenated methines at δH
4.50 (dd, J = 5.7, 2.4 Hz), δH 4.80 (d, J = 5.7 Hz), and δH 5.80
(d, J = 2.4 Hz), as well as four aromatic or olefinic methines at
δH 6.75 (m), 6.78 (m, 2H), and 7.26 (t, J = 7.6 Hz). Fifteen
signals were observed in the 13C NMR (Table 1) and DEPT
spectra of 1. These signals resulted from one methyl (δC 22.8),
one methylene (δC 59.3), three oxygenated methines (δC 69.3,
75.6, and 78.8), four olefinic methines (δC 115.7, 123.5, 134.4,
and 145.5), four quaternary carbons (δC 116.2, 138.1, 142.1,
and 161.1), and two carbonyl carbons (δC 170.2 and 193.3).
Analyzing its 1H and 13C NMR data, this compound showed
high similarity to 2.20 Thus, the structure of 1 was suggested as
Figure 1. Structures of all isolates 1−8.
Table 1. 1H and 13C NMR Data of 1 in CD3OD
a
no δH (mult, J in Hz) δc, type
1 193.3, C
2 138.1, C
3 6.78, m 145.5, CH
4 4.80, d (5.7) 69.3, CH
5 4.50, dd (5.7, 2.4) 75.6, CH
6 5.80, d (2.4) 78.8, CH
7 4.27, s 59.3, CH3
1′ 116.2, C
2′ 161.1, C
3′ 6.75, m 115.7, CH
4′ 7.26, t (7.6) 134.4, CH
5′ 6.78, m 123.5, CH
6′ 142.1, C
7′ 2.56, s 22.8, CH3
8′ 170.2, C
a1H and 13C NMR data (δ) were measured at 400 and 100 MHz,
respectively; chemical shifts are in ppm; J values in Hz are in
parentheses.
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one of the stereoisomers of the polyketide secondary
metabolite 2.
The COSY correlations of H-3′ (δH 6.75)/H-4′ (δH 7.26)/
H-5′ (δH 6.78) and the HMBC correlations of CH3-7′ (δH
2.56) with C-1′ (δC 116.2), C-2′ (δC 161.1), C-5′ (δC 123.5),
and C-6′ (δC 142.1) as well as H-4′ (δH 7.26) with C-2′ (δC
161.1) and C-6′ (δC 142.1) suggested hydroxy and methyl
groups attached to a benzene ring moiety. This partial
structure of 1 was deduced and showed similarity to 722
with an ester carbonyl moiety. The HMBC correlation of H-6
(δH 5.80) with C-8′ (δC 170.2) suggested the connection of
the ester carbonyl unit. Other parts of the COSY correlations,
H-4 (δH 4.80)/H-5 (δH 4.50)/H-6 (δH 5.80), and HMBC
correlations, H-6 (δH 5.80) with C-1 (δC 193.3) as well as H-7
(δH 4.27) with C-1 (δC 193.3), C-2 (δC 138.1), and C-3 (δC
145.5), established the linkage of a carbonyl functionality
(Figure 2).
The relative configuration of 1 was deduced by the analysis
of NOESY correlations and comparison with the chemical
shifts with the published compounds.20 The NOESY
correlations of H-4/H-5/H-6 suggested that these protons
showed the same orientation (Figure 3).
Compared with 2, the missing correlation between H-5 and
H-6 suggested that these two protons were pointed at different
orientations. The proposed stereochemistry of 1 was further
confirmed by X-ray single crystallographic analysis (Figure 4),
and the name of the new compound, epicorepoxydon A, was
given. Crystallographic data for 1 have been deposited at the
Cambridge Crystallographic Data Centre with the deposition
number of CCDC 1993524.
The structure of compound 6 was only displayed on the
PubChem database with no reference nor spectroscopic data.
The 1H and 13C NMR data of 6 are summarized in Table S1.
Interestingly, a series of unusual simple phenolic/polyphenolic
benzyl/benzoic compounds with no common para-hydroxyl
substitution, such as compounds 3−7, were identified from this
species for the first time (Table S4).
According to previous reports in the literature, E. sorghinum
is regarded as the major component of the sorghum grain-mold
disease complex and a producer of tenuazonic acid (TeA) that
inhibits protein biosynthesis in sorghum.13−15 In the past,
many researchers considered Alternaria sp. as the major
producer of TeA causing food contamination. But in recent
years, some researchers found that E. sorghinum (formerly
identified as Phoma sorghium) produces TeA even more than
Alternaria sp.13,23 These findings encouraged us to investigate
if TeA was available in our E. sorghinum extract. After
examining the extract by HPLC, TeA was observed under the
standard separation condition (Figure S1). However, TeA was
not separated because it was present in minute quantity. Such
observation suggested that the isolated endophytic strain E.
sorghinum did not produce large amounts of TeA under liquid
PDB media cultivation, and the type of media significantly
affected the metabolic profile of the fungal extract.
The structural similarities of the isolated compounds
encouraged us to propose a plausible biosynthetic pathway
of the isolated polyketide secondary metabolites based on the
previously isolated analogs with similar partial structures
(Figure 5).22,24 One acetyl-CoA and three malonyl-CoA
combine to form a polyketide precursor that undergoes
dehydration to afford 7. Compound 7 undergoes decarbox-
ylation followed by hydroxylation to produce 3 and 4.
Compound 4 undergoes dehydrogenation and hydroxylation
to yield isoepoxydon.24 Isoepoxydon undergoes hydrolysis to
form (−)-gabosine C and (−)-gabosine E, respectively.
(−)-Gabosine C reacts with 7 to obtain 1. On the other
hand, (−)-gabosine E reacts with 7 to furnish 2. Theoretically,
the hydrolysis that occurred on the epoxide at the C-5 and C-6
of isoepoxydon would form four stereoisomers. The rule of
acid-catalyzed hydroxylation of epoxides should result in a
trans dihydroxy rather than a cis arrangement. However,
biosynthesis has frequently shown that arrangements of
chemical functions may not be transmitted acceding to
chemical priority. Therefore, rare cis products may be available
in the biosynthetic pathway.
Fungi generated many secondary metabolites that demon-
strated a plethora of biological activities.1,25 The isolated
compounds were subjected to a panel of biological assays. The
crude extract was subjected to anti-inflammatory assay and by
utilizing bioassay-guided fractionation, two potential candi-
dates were purified and identified. Compound 6 exhibited
promising inhibitory activity on both superoxide anion
generation (IC50 0.25 ± 0.02 μM) and elastase release (IC50
1.60 ± 0.05 μM). Compound 4 also showed an anti-
inflammatory effect by inhibiting superoxide anion generation
with an IC50 value of 4.54 ± 0.52 μM. The presence of 4 and 6
in large quantities in the extract suggested that these
Figure 2. Key COSY (bold lines) and HMBC (red arrows)
correlations of 1.
Figure 3. Key NOESY (blue double-headed arrows) correlations of 1.
Figure 4. X-ray single crystallographic analysis of 1.
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components are responsible for the anti-inflammatory activity
of the extract.
Certain secondary metabolites from endophytic fungi such
as Epicoccum nigrum exhibited anti-inflammatory and inhibited
the platelet-activating factor-induced release of β-glucuronidase
from rat polymorphonuclear leukocytes in vitro.26 Bisdethiobis-
(methylthio)-gliotoxin from Penicillium terlikowskii was found
to inhibit the platelet-activating factor (PAF)-induced rabbit
platelet aggregation with IC50 8.4 μM.
27 Fungal toxins such as
trichothecenes were found to induce hematological disorders
including thrombopenia, neutropenia, and aplastic anemia in
animals and humans.28 E. sorghinum causes a human and
animal hematological disease, which is known as onyalai, after
eating sorghum grains contaminated with the fungus.13,15
Onyalai is characterized by the presence of blood blisters in the
mouth and a form of thrombocytopenic purpura.13,16 Platelets
are the smallest blood cells that play an indispensable role in
maintaining hemostasis. Dysfunction in the platelet activation
process is manifested in hemorrhagic and thrombotic related
diseases.29 Collagen is a part of the primary hemostatic
agonists, whereas thrombin, ADP, and TXA2 are secondary
stimulants.30 Angiogenesis plays an important role in
physiological conditions such as bone remodeling, embryonic
development, reproduction, and tissue repair. The process of
angiogenesis involves endothelial cell proliferation, migration,
and tube formation to form new blood vessels.31 Until now, no
one has investigated the relation between onyalai and the
natural components isolated from E. sorghium. Among all
Figure 5. Plausible biosynthetic pathway of the five polyketide secondary metabolites from E. sorghinum.
Figure 6. Antiplatelet aggregation activity of compounds 1 and 2. Aspirin was used as the positive control. Results are presented as mean ± SEM (n
= 3). *P < 0.05 as compared with the control. ***P < 0.005 as compared with the control.
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isolates, 2 displayed potent activity against two platelet
aggregation factors, collagen and U46619. The IC50 values of
2 were 168.74 and 181.85 μM, respectively, while aspirin was
the positive control. It also possessed significant antiangiogenic
activity with an IC50 value of 11.0 ± 0.50 μM (Figure 6).
Although 1 is the C-6 position epimer of 2, it was inactive in
cytotoxicity, anti-inflammatory, antiplatelet aggregation, and
antiangiogenesis assays. Compound 6 exhibited potent
antiangiogenic activity with an IC50 65.0 ± 5.50 μM. The
cytotoxicity of all isolates was not significant against the tested
cancer cells of A549, Hep-G2, and MDA-MB-231.
■ CONCLUSIONS
The chemical and biological investigation of the endophytic
fungal strain E. sorghinum was carried out resulting in the
isolation of one new and seven known compounds; the
biosynthetic pathway of epicorepoxydon A (1) was proposed.
The biological activities of 2, 4, and 6 in this study were
reported for the first time. Interestingly, the different
stereochemistry at the C-6 position between 1 and 2 resulted
in a significant difference in their biological activities. Our
findings suggested the first insights into the antiplatelet
aggregation and antiangiogenesis activities of E. sorghium
components.
■ MATERIALS AND METHODS
Isolation of Compounds. In the current study, the culture
broth of E. sorghinum was cultivated using 120 Erlenmeyer
flasks (500 mL); each flask contained 300 mL of potato
dextrose broth (PDB) media. The flasks were incubated for 7
days using a rotatory shaker (150 rpm and 25 °C). After
incubation, 36 L of the whole culture broth was filtered to
separate the filtrate from the mycelia. The filtrate was extracted
with ethyl acetate (EtOAc) and concentrated under reduced
pressure to obtain the EtOAc extract (9.3 g). The EtOAc
extract was subjected to a series of column chromatography
procedures to yield the new compound, epicorepoxydon A (1),
along with seven known compounds including 4,5-dihydroxy-
6-(6′-methylsalicyloxy)-2-hydroxymethyl-2-cyclohexenl-one
(2),20 3-hydroxybenzyl alcohol (3),32 gentisyl alcohol (4),33
hydroxymethyl resorcinol (5),34 6-(hydroxymethyl)benzene-
1,2,4-triol (6), 2-hydroxy-6-methyl benzoic acid (7),22 and
hydroxytyrosol (8).35 All isolates were deduced by analyzing
and comparing their spectroscopic data with the literature
values.
Fungal Material. The fungus E. sorghinum was isolated
from the leaves of A. donax collected from the Dr. Cecilia Koo
Botanic Conservation Center (KBCC), Pingtung, Taiwan,
which deposits over 30 000 living plants. The leaves of A.
donax were washed and air-dried. To clean the surface, the
dried leaves were immersed in 0.01% Tween 20(aq), dd-H2O,
and 0.01% bleach(aq) for 1 min. The leaves were treated with
75% ethanol then the central parts (5 × 5 mm2) of the leaves
were sliced by sterilized scissors and seeded on the potato
dextrose agar. The fungal strains were maintained in potato
dextrose agar media at 25 °C. After duplicated purification, the
mycelia of the pure strain were deposited in 2 mL tubes
containing 1.5 mL of potato dextrose broth media as well as
0.2 mL of sterilized glycerol and kept at −80 °C. The fungal
strain was identified by Chi-Ying Li and Ching-Chia Chang. A
voucher specimen (code number: K060107S-B) was deposited
at the Graduate Institute of Natural Products, College of
Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.
Species Identification. The fungal sample was preserved
in phosphate-buffered saline (PBS) at ambient temperature.
The DNA extraction was accomplished by utilizing AxyPrep
Multisource Genomic DNA Miniprep Kit (AxyPrep,
#02815KC1) according to the manufacturing company’s
instructions. A pair of primers of the internal transcribed
spacer, ITS 4 and ITS 5 (ITS 4: 5′-TCCTCCGCTTATTGA-
TATGC3′/ITS 5: 5′GGAAGTAAAAGTCGTAACAAGG-3′),
was selected for amplifying the 18S rRNA. Polymerase chain
reaction (PCR) amplifications were carried out by FlexCycler2
(Analytik, Jena, Germany) under the following conditions: 95
°C (5 min), 30 cycles of 95 °C (30 s), 55 °C (30 s), and 72 °C
(40 s), with the last extension at 72 °C (7 min). The amplified
PCR products were further delivered to the Mission Biotech
Co., Ltd. (Taipei, Taiwan) for sequencing services and blasted
with the National Center for Biotechnology Information
(NCBI) database. The blasting results displayed that the
sample shared 99.5% sequence identity with E. sorghinum
(GenBank accession number: KX611667.1).
Fermentation, Extraction, and Isolation. The whole
fermented broth (36 L) was filtered through filter paper to
separate the supernatant from the mycelia. The filtrate was
extracted by ethyl acetate (EtOAc) and concentrated by a
rotary evaporator to obtain the EtOAc crude extract (9.3 g).
This EtOAc crude extract (9.3 g) was subjected to Sephadex
LH-20 column chromatography eluted via MeOH to yield five
fractions (Fr. 1−Fr. 5). Fraction 3 (3020.3 mg) was separated
using silica gel column chromatography and stepwise eluted by
CH2Cl2/MeOH (29:1 to 9:1) to afford five subfractions (Fr. 3-
1−Fr. 3-5). Fraction 3-2 (613.8 mg) was subjected to silica gel
column and stepwise eluted with CH2Cl2/MeOH (49:1 to
9:1) to give eight subfractions (Fr. 3-2-1−Fr. 3-2-8). Fraction
3-2-1 (459.5 mg) was further isolated by silica gel open
column and eluted stepwise with CH2Cl2/MeOH (17:1 to
9:1) to get 3 (386.8 mg). Fraction 3-2-2 (17.3 mg) was further
purified by reversed-phase (RP) HPLC (Luna 5 μm Phenyl-
Hexyl, 250 × 10 mm, Phenomenex, flow rate = 2.0 mL/min,
UV detector) eluted with 45% MeOH(aq) to afford 5 (10.8
mg). Fraction 3-3 (1178.6 mg) was submitted to a silica gel
open column chromatography with a gradient of CH2Cl2/
MeOH (33:1 to 9:1) to furnish seven subfractions (Fr. 3-3-1−
Fr. 3-3-7). Fraction 3-3-3 (448.2 mg) was chromatographed on
a silica gel open column and eluted stepwise with CH2Cl2/
MeOH (33:1 to 9:1) to obtain five subfractions (Fr. 3-3-3-1−
3-3-3-5). Fraction 3-3-3-1 (67.1 mg) was further isolated by
RP-HPLC (Luna 5 μm Phenyl-Hexyl, 250 × 10 mm,
Phenomenex, flow rate = 2.0 mL/min, UV detector) using
30% MeOH(aq) as the eluent to yield 1 (7.6 mg) and 8 (2.1
mg). Fraction 3-3-3-2 (297.4 mg) was fractionated by silica gel
column chromatography and eluted stepwise with CH2Cl2/
MeOH (24:1 to 9:1) to afford eight subfractions (Fr. 3-3-3-2-
1−3-3-3-2-8). Fraction 3-3-3-2-1 (149.4 mg) was further
separated by RP-HPLC (Luna 5 μm Phenyl-Hexyl, 250 × 10
mm, Phenomenex, flow rate = 2.0 mL/min, UV detector) and
eluted with 37% MeOH(aq) to obtain 2 (70.5 mg) and 6 (45.3
mg). Fraction 3-3-4 (263.2 mg) was subjected to silica gel
column chromatography with a gradient elution of CH2Cl2/
MeOH (29:1 to 9:1) to furnish eight subfractions (Fr. 3-3-4-
1−3-3-4-7). Fraction 3-3-4-3 (18.3 mg) was further purified by
RP-HPLC (Luna 5 μm Phenyl-Hexyl, 250 × 10 mm,
Phenomenex, flow rate = 2.0 mL/min, UV detector) eluted
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with 30% MeOH(aq) to afford 4 (6.2 mg). Fraction 3-5 (500.3
mg) was separated using silica gel column chromatography
eluted stepwise with CH2Cl2/MeOH (21:1 to 9:1) to give 7
(346.1 mg).
Epicorepoxydon A (1): Brown acicular crystals; [α]D
25 −25
(c 0.05, MeOH); UV (MeOH) λmax (log ε) 211 (3.79), 241
(3.42), 308 (2.91) nm; IR (neat) νmax: 3448, 1635 cm
−1; 1H
NMR (CD3OD, 400 MHz) and
13C NMR (CD3OD, 100
MHz) data shown in Table 1; HR-ESI-MS m/z 307.0822 [M
− H]− (calcd for C15H16O7, 307.0823).
TeA Examination. The EtOAc crude extract and TeA
standard were monitored by RP-HPLC on a Cosmosil
reversed-phase column (C-18, 250 × 4.6 mm2, 5 μm, 1.0
mL/min, Nacalai Tesque, Kyoto, Japan) with acetonitrile and
water (0.1% H3PO4) as the mobile phase (0−5 min: 20:80, 5−
20 min: from 20:80 to 0:100, 20−30 min: 0:100).
Anti-inflammatory Activity Assay. The method for anti-
inflammatory activity assay was similar to the method
previously described.36 In brief, human neutrophils were
collected from healthy volunteers through venipuncture and
separated by Ficoll centrifugation. Dextran was employed for
sedimentation. After resuspension in calcium (Ca2+)-free
HBSS buffer at pH 7.4, the isolated neutrophils were incubated
at 4 °C before use.
Measurement of Superoxide Generation. The measure-
ment of superoxide generation has been previously de-
scribed.36 In brief, neutrophils (6 × 105 cell/mL) were
balanced in ferricytochrome c (0.5 mg/mL) and Ca2+ (1 mM)
at 37 °C for 5 min and then incubated with 0.1% DMSO or the
tested samples for another 5 min. Cells were activated by
utilizing fMLP (0.1 μM) for 10 min and treated with
cytochalasin B (CB, 1 μg/mL) for 3 min. The spectropho-
tometer (U-3010; Hitachi) was employed for continuous
detection of the changes in absorbance at 550 nm.
Measurement of Elastase Release. The measurement of
elastase release has been previously described.36 In brief,
neutrophils (6 × 105 cell/mL) were balanced in MeO-Suc-Ala-
Ala-Pro-Val-p-nitroanilide (100 μM) and Ca2+ (1 mM) at 37
°C for 5 min and incubated with 0.1% DMSO or the tested
samples for another 5 min. Cells were activated with fMLP
(0.1 μM) for 10 min and treated with CB (0.5 μg/mL) for 3
min. The spectrophotometer (U-3010; Hitachi) was employed
for continuous detection of the changes in absorbance at 550
nm.
Antiangiogenesis Activity Assay. Isolation and Culti-
vation of Human EPCs. Peripheral blood (80 mL) was
collected from healthy volunteers with informed consent
before collection. The peripheral blood mononuclear cells
(PBMCs) were fractionated from other blood components by
centrifugation on Ficoll-Paque Plus (Amersham Biosciences,
Uppsala, Sweden) based on the manufacturer’s instructions.
Utilizing CD34 MicroBead kit and MACS Cell Separation
System (Miltenyi Biotec, Bergisch Gladbach, Germany), the
CD34-positive progenitor cells were obtained from the
separated PBMCs. The isolation and maintenance of CD34-
positive EPCs were carried out as previously described.37
Tube Formation Assay. Matrigel (BD Biosciences, Bedford,
MA) was utilized to facilitate the differentiation of EPCs into a
capillary tube-like structure. For polymerization, Matrigel was
loaded into 96-well plates and maintained at 37 °C for 30 min.
After gel formation, EPCs (1.5 × 104 cells) were seeded per
well on the layer of polymerized Matrigel in MV2 medium
(containing 2% FBS) with the presence of tested compounds
and incubated at 37 °C for 24 h. The methods were performed
as previously described.37
Cytotoxicity Assay. EPCs were incubated using 96-well
plates in a density of 5 × 103 cells in each well. Cells were
primed with MV2 medium (containing 2% FBS) in the
indicated concentration of the tested compounds for 24 h. The
percentage of LDH release was measured by the ratio of LDH
activity in the medium to LDH activity in the cell lysate.37
Antiplatelet Activity Assay. Preparation of Washed
Human Platelets. The platelet suspension was prepared on the
basis of the previously described procedures.38 Briefly, human
blood anticoagulated with acid citrate dextrose was collected
from healthy donors, who had not taken any medicines during
the previous 2 weeks. Platelets were suspended in Tyrode’s
solution (2 mM Ca2+, 11.1 mM glucose, and 3.5 mg/mL
bovine serum albumin) at a concentration of 3 × 108 platelets/
mL.
Measurement of Platelet Aggregation. Before adding the
platelet activators, the platelet suspension was incubated with
dimethyl sulfoxide (DMSO) as a vehicle or with the tested
samples at different concentrations at 37 °C for 3 min under
stirring (80.5 × g). After adding the indicated concentration of
platelet inducers (U46619 1 μM; collagen 5 μg/mL), the level
of platelet aggregation was estimated as the maximal increase
of light transmission within 5 min. The light-transmission
aggregometer (Chrono-Log Co., Havertown, PA) was
employed for measuring platelet aggregation.38
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